Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief (NCT05711953) | Clinical Trial Compass
CompletedNot Applicable
Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief
Italy26 participantsStarted 2021-06-12
Plain-language summary
The application of a novel topical formulation for the treatment of muscular pain and stiffness (Egyfil), containing hyaluronic acid, SH-Polypeptide-6 and SH-Oligopeptide-1, is investigated to evaluate efficacy and safety in 26 patients with stiffness and pain. Single-Arm, Pre-Market, interventional study.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. signed participants informed consent form (ICF);
✓. male or Female, aged \> 18 years at the time of the signature of ICF;
✓. 3 to 10 rating according to the Numerical Rating Scale (NRS), applied in participants with muscle tension pain;
✓. willing to follow all study procedures;
✓. willing to follow indications.
Exclusion criteria
✕. use of analgesics within the 24 hours prior to V1;
✕. damaged skin in the area of treatment;
✕. infective or prior inflammatory processes near the area of treatment;
✕. ongoing cutaneous allergies;
✕. serious and chronical pathological skin conditions (i.e., rosacea, psoriasis, vitiligo) including diagnosticated cancer with/without ongoing antitumor therapy;